Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SECUKINUMAB Cause Therapeutic response decreased? 862 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 862 reports of Therapeutic response decreased have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.6% of all adverse event reports for SECUKINUMAB.

862
Reports of Therapeutic response decreased with SECUKINUMAB
0.6%
of all SECUKINUMAB reports
127
Deaths
296
Hospitalizations

How Dangerous Is Therapeutic response decreased From SECUKINUMAB?

Of the 862 reports, 127 (14.7%) resulted in death, 296 (34.3%) required hospitalization, and 227 (26.3%) were considered life-threatening.

Is Therapeutic response decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 862 reports have been filed with the FAERS database.

What Other Side Effects Does SECUKINUMAB Cause?

Drug ineffective (27,434) Psoriasis (21,976) Pain (15,244) Arthralgia (13,769) Fatigue (9,406) Psoriatic arthropathy (8,900) Pruritus (8,755) Malaise (8,570) Rash (8,023) Condition aggravated (7,536)

What Other Drugs Cause Therapeutic response decreased?

DUPILUMAB (7,824) ETANERCEPT (3,460) ONABOTULINUMTOXINA (2,685) METHOTREXATE (2,668) INFLIXIMAB (1,991) RITUXIMAB (1,728) LEFLUNOMIDE (1,574) TOCILIZUMAB (1,512) HYDROXYCHLOROQUINE (1,485) ADALIMUMAB (1,357)

Which SECUKINUMAB Alternatives Have Lower Therapeutic response decreased Risk?

SECUKINUMAB vs SELADELPAR LYSINE SECUKINUMAB vs SELEGILINE SECUKINUMAB vs SELENIUM SECUKINUMAB vs SELENIUM SULFIDE SECUKINUMAB vs SELEXIPAG

Related Pages

SECUKINUMAB Full Profile All Therapeutic response decreased Reports All Drugs Causing Therapeutic response decreased SECUKINUMAB Demographics